PredictSURE IBD for inflammatory bowel disease prognosis: ulcerative colitis (MIB313)Product type:AdviceProgramme:Medtech innovation briefingPublished: 10 January 2023
ProciseDx point-of-care platform for inflammatory bowel disease (MIB302)Product type:AdviceProgramme:Medtech innovation briefingPublished: 12 July 2022
Remsima (infliximab biosimilar) for subcutaneous injection for managing Crohn’s disease and ulcerative colitis (ES35)Product type:AdviceProgramme:Evidence summaryPublished: 24 February 2021
Point-of-care and home faecal calprotectin tests for monitoring treatment response in inflammatory bowel disease (MIB132)Product type:AdviceProgramme:Medtech innovation briefingPublished: 4 December 2017
RIDASCREEN tests for monitoring infliximab in inflammatory bowel disease (MIB109)Product type:AdviceProgramme:Medtech innovation briefingPublished: 20 June 2017